We are live on
!
Find out more
Jazz Pharmaceuticals
JAZZ
JAZZ
384 hedge funds and large institutions have $5.75B invested in Jazz Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 137 increasing their positions, 148 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
15% more capital invested
Capital invested by funds: $5.01B → $5.75B (+$747M)
5.04% more ownership
Funds ownership: 89.31% → 94.35% (+5%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
7% less repeat investments, than reductions
Existing positions increased: 137 | Existing positions reduced: 148
6% less funds holding
Funds holding: 408 → 384 (-24)
31% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 68
53% less call options, than puts
Call options by funds: $22.4M | Put options by funds: $47.8M
Holders
384
Holders Change
-24
Holders Change %
-5.88%
% of All Funds
7.87%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
47
Increased
137
Reduced
148
Closed
68
Calls
$22.4M
Puts
$47.8M
Net Calls
-$25.3M
Net Calls Change
-$16.4M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$142M |
| 2 |
Millennium Management
New York
|
+$53.3M |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
+$51.9M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$40.1M |
| 5 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$36.3M |
